Meat Science 2010-11-01

Clenbuterol residues in pig muscle after repeat administration in a growth-promoting dose.

Jelka Pleadin, Ana Vulić, Nina Persi, Nada Vahcić

Index: Meat Science 86 , 733-7, (2010)

Full Text: HTML

Abstract

The aim of this study was to determine the level of clenbuterol residues in muscle tissue of pigs after repeat administration in a growth-promoting dose. An anabolic dose of clenbuterol (20 μg/kg body mass per day) was administered orally to experimental group (n=12) for 28 days, whereas control animals (n=3) were left untreated. Clenbuterol treated pigs were randomly sacrificed (n=3) on days 0, 3, 7 and 14 of treatment discontinuation and clenbuterol residues determined in muscle tissue. Determination of residual clenbuterol was by enzyme-linked immunosorbent assay (ELISA) as a screening method and liquid chromatography tandem mass spectrometry (LC-MS/MS) as a confirmation method. The highest clenbuterol content in the muscle of treated animals was recorded on day 0 of treatment cessation (4.40±0.37 ng/g) and significantly (p<0.05) exceeded the maximum residue limit (MRL) of 0.1 ng/g. On day 3 of withdrawal, it was 0.49±0.22 ng/g and on day 7 0.10±0.02 ng/g (at MRL); on day 14 of treatment discontinuation, clenbuterol content was below the limit of detection (<0.1 ng/g) in all samples. Administration of clenbuterol as a growth promoter in pig production could lead to residues in meat for human consumption up to 7 days after treatment discontinuation.Copyright © 2010 The American Meat Science Association. Published by Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Mutagenicity and DNA-damaging potential of clenbuterol and its metabolite 4-amino-3,5-dichlorobenzoic acid in vitro.

2015-03-01

[Food Chem. Toxicol. 77 , 82-92, (2015)]

Detection of clenbuterol hydrochloride residuals in pork liver using a customized surface plasmon resonance bioanalyzer.

2015-01-01

[PLoS ONE 10(3) , e0122005, (2015)]

Study of interaction between agonists and asn293 in helix VI of human beta(2)-adrenergic receptor.

1999-11-01

[Mol. Pharmacol. 56 , 909, (1999)]

The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo.

1999-09-01

[Inflamm. Res. 48 , 497-502, (1999)]

Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors.

[Brain Res. Brain Res. Rev. 30 , 176-188, (1999)]

More Articles...